Changing the Game in Drug Development Brochure Changing the Game in Drug Development At Certara, we are innovators, dedicated to helping our clients develop new therapies and target…CertaraMarch 19, 2018
Using a Pharmacology to Payer Framework to Support Product Development Blog Using a Pharmacology to Payer Framework to Support Product Development Modeling and simulation (M&S) of complex systems has primarily advanced vertically in differing scientific domains…CertaraMarch 16, 2018
An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) Publication An Analysis on Distribution and Inter-relationships of Biomarkers Under Rivaroxaban in Japanese Patients with Non-valvular Atrial Fibrillation (CVI ARO 1) CertaraMarch 15, 2018
Using Virtual Twin® Technology to Predict Drug Exposure in Individual Patients On-Demand Webinar Using Virtual Twin® Technology to Predict Drug Exposure in Individual Patients In this webinar, Dr. Tom Polasek, a clinical pharmacologist at Certara Strategic Consulting, explained how…CertaraMarch 8, 2018
Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption Blog Skin in the Game: Mechanistic Modeling of Dermal Drug Absorption The ability to estimate systemic exposure from dermal absorption is essential in developing new dermatological…CertaraMarch 2, 2018
Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics Publication Cost-utility Analysis of Antiviral Use Under Pandemic Influenza Using a Novel Approach—Linking Pharmacology, Epidemiology and Heath Economics CertaraMarch 1, 2018
A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination with Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer Publication A Randomized, Controlled Trial Evaluating the Efficacy and Safety of BTH1677 in Combination with Bevacizumab, Carboplatin, and Paclitaxel in First-line Treatment of Advanced Non-small Cell Lung Cancer CertaraFebruary 27, 2018
Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation Publication Incorporation of GSTA1 Genetic Variations into a Population Pharmacokinetic Model for IV Busulfan in Pediatric Hematopoietic Stem Cell Transplantation CertaraFebruary 22, 2018
Surveying the Lay of the Land for Modeling & Simulation for Global Regulatory Submissions Blog Surveying the Lay of the Land for Modeling & Simulation for Global Regulatory Submissions Analogous to how a geologist surveys the “lay of the land” to determine if oil…CertaraFebruary 16, 2018
Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor Publication Model-informed Drug Development for Ixazomib, an Oral Proteasome Inhibitor CertaraFebruary 15, 2018